Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-May-24 5:04 PM View:  | Bvf Partners L P/il 10% Owner | Eledon Pharmaceuticals, Inc. (NVUS) | 09-May-24 | Purchase | 1,927,940 | -- | -- | 45% 4.29M to 6.22M | |
| 09-May-23 8:25 PM View: | Bvf Partners L P/il 10% Owner | Eledon Pharmaceuticals, Inc. (NVUS) | 05-May-23 | Purchase | 1,978,930 | -- | -- | 86% 2.31M to 4.29M | |
| 23-Nov-22 4:05 PM View: | Perrin Steven President Director | Eledon Pharmaceuticals, Inc. (NVUS) | 23-Nov-22 | Private Purchase | 1,000 | $2.60 | $2,596.90 | 100% 0 to 1.0K | |
| 21-Dec-21 4:05 PM View: | Gros David-Alexandre C Chief Executive Officer Director | Eledon Pharmaceuticals, Inc. (NVUS) | 20-Dec-21 | Private Purchase | 2,000 | $4.48 | $8,960.00 | 29% 7.0K to 9.0K | |
| 14-Jun-21 5:24 PM View: | Little Paul Sean CHIEF FINANCIAL OFFICER | Eledon Pharmaceuticals, Inc. (NVUS) | 11-Jun-21 | Market Purchase | 10,000 | $8.87 | $88,700.00 | 100% 0 to 10.0K | (< 1%) |
| 10-Jun-21 5:25 PM View: | Gros David-Alexandre C Chief Executive Officer Director | Eledon Pharmaceuticals, Inc. (NVUS) | 09-Jun-21 | Market Purchase | 3,000 | $8.01 | $24,030.00 | 100% 0 to 3.0K | |
| 28-Dec-20 4:47 PM View: | Bvf Partners L P/il | Eledon Pharmaceuticals, Inc. (NVUS) | 22-Dec-20 | Conversion | 1,289,630 | -- | -- | 665% 193.93K to 1.48M | |
| 04-Dec-20 5:17 PM View: | Orbimed Israel Gp Ltd. 10% Owner | Eledon Pharmaceuticals, Inc. (NVUS) | 02-Dec-20 | Market Sale | 103,200 | $21.60 | $2,229,120.00 | (58%) 176.85K to 73.65K | 29% |
| 06-Nov-20 6:46 PM View: | Logos Global Management Lp 10% Owner | Eledon Pharmaceuticals, Inc. (NVUS) | 30-Oct-20 | Market Purchase | 92,040 | $25.44 | $2,341,710.00 | 63% 145.0K to 237.04K | (39%) |
| 06-Nov-20 6:46 PM View: | Logos Global Management Lp 10% Owner | Eledon Pharmaceuticals, Inc. (NVUS) | 30-Oct-20 | Market Sale | 12,969 | $26.65 | $345,559.00 | (5%) 237.04K to 224.07K | 42% |
| 22-May-19 4:12 PM View: | Turkel Catherine C. President | Eledon Pharmaceuticals, Inc. (NVUS) | 21-May-19 | Market Sale | 1,914 | $1.91 | $3,658.42 | (2%) 90.58K to 88.66K | 49% |
| 22-May-19 4:01 PM View: | Flesher Gregory J. Chief Executive Officer Director | Eledon Pharmaceuticals, Inc. (NVUS) | 21-May-19 | Market Sale | 2,937 | $1.91 | $5,613.78 | (2%) 159.85K to 156.92K | 49% |
| 22-May-19 4:02 PM View: | Kuwahara Jon See Remarks | Eledon Pharmaceuticals, Inc. (NVUS) | 21-May-19 | Market Sale | 1,058 | $1.91 | $2,022.26 | (15%) 7.03K to 5.97K | 49% |
| 22-May-19 4:02 PM View: | Kuwahara Jon See Remarks | Eledon Pharmaceuticals, Inc. (NVUS) | 20-May-19 | Market Sale | 4,218 | $1.96 | $8,274.03 | (37%) 11.25K to 7.03K | 51% |
| 22-May-19 4:12 PM View: | Turkel Catherine C. President | Eledon Pharmaceuticals, Inc. (NVUS) | 20-May-19 | Market Sale | 7,623 | $1.96 | $14,953.30 | (8%) 98.2K to 90.58K | 51% |
| 22-May-19 4:01 PM View: | Flesher Gregory J. Chief Executive Officer Director | Eledon Pharmaceuticals, Inc. (NVUS) | 20-May-19 | Market Sale | 11,701 | $1.96 | $22,952.70 | (7%) 171.56K to 159.85K | 51% |
| 06-May-19 5:28 PM View: | Chimovits Erez Director | Eledon Pharmaceuticals, Inc. (NVUS) | 02-May-19 | Market Purchase | 646,204 | $3.10 | $2,003,230.00 | 25% 2.54M to 3.18M | (69%) |
| 06-May-19 5:30 PM View: | Orbimed Israel Gp Ltd. Director 10% Owner | Eledon Pharmaceuticals, Inc. (NVUS) | 02-May-19 | Market Purchase Duplicate | 646,204 | $3.10 | $2,003,230.00 | 25% 2.54M to 3.18M | (69%) |
| 02-May-19 4:47 PM View: | Lifesci Index Partners LLC 10% Owner | Eledon Pharmaceuticals, Inc. (NVUS) | 30-Apr-19 | Market Sale | 200 | $2.70 | $540.00 | (< 1%) 1.07M to 1.07M | 64% |
| 18-Mar-19 4:23 PM View: | Flesher Gregory J. Chief Executive Officer Director | Eledon Pharmaceuticals, Inc. (NVUS) | 14-Mar-19 | Grant | 25,000 | -- | -- | 17% 146.56K to 171.56K | |
| 18-Mar-19 4:24 PM View: | Turkel Catherine C. President | Eledon Pharmaceuticals, Inc. (NVUS) | 14-Mar-19 | Grant | 20,000 | -- | -- | 25% 79.0K to 99.0K | |
| 13-Sep-18 8:00 PM View: | Turkel Catherine C. President | Eledon Pharmaceuticals, Inc. (NVUS) | 12-Sep-18 | Market Purchase | 16,632 | $5.02 | $83,476.00 | 27% 62.37K to 79.0K | (81%) |
| 13-Sep-18 8:00 PM View: | Turkel Catherine C. President | Eledon Pharmaceuticals, Inc. (NVUS) | 11-Sep-18 | Market Purchase | 17,048 | $4.56 | $77,670.70 | 38% 45.32K to 62.37K | (79%) |
| 07-Sep-18 8:00 PM View: | Turkel Catherine C. President | Eledon Pharmaceuticals, Inc. (NVUS) | 05-Sep-18 | Market Purchase | 805 | $3.97 | $3,192.63 | 2% 44.52K to 45.32K | (75%) |
| 15-Mar-18 6:53 PM View: | Kuwahara Jon See Remarks | Eledon Pharmaceuticals, Inc. (NVUS) | 13-Mar-18 | Grant | 11,250 | -- | -- | 100% 0 to 11.25K | |
| 15-Mar-18 6:46 PM View: | Turkel Catherine C. President | Eledon Pharmaceuticals, Inc. (NVUS) | 13-Mar-18 | Grant | 20,000 | -- | -- | 82% 24.52K to 44.52K | |
| 15-Mar-18 6:51 PM View: | Flesher Gregory J. Chief Executive Officer Director | Eledon Pharmaceuticals, Inc. (NVUS) | 13-Mar-18 | Grant | 30,700 | -- | -- | 26% 115.86K to 146.56K | |
| 11-May-17 8:30 PM View: | Ocampo Christine See Remarks | Eledon Pharmaceuticals, Inc. (NVUS) | 10-May-17 | Purchase | 10,010 | $9.99 | $99,999.90 | 86% 11.58K to 21.59K | |
| 11-May-17 8:33 PM View: | Turkel Catherine C. Chief Development Officer | Eledon Pharmaceuticals, Inc. (NVUS) | 10-May-17 | Purchase | 11,111 | $9.99 | $110,999.00 | 83% 13.41K to 24.52K | |
| 11-May-17 8:36 PM View: | Flesher Gregory J. Chief Executive Officer Director | Eledon Pharmaceuticals, Inc. (NVUS) | 10-May-17 | Purchase | 58,959 | $9.99 | $589,000.00 | 104% 56.9K to 115.86K | |
| 11-May-17 4:13 PM View: | Orbimed Israel Gp Ltd. Director 10% Owner | Eledon Pharmaceuticals, Inc. (NVUS) | 09-May-17 | Grant | 2,537,110 | -- | -- | 100% 0 to 2.54M | |
| 15-Mar-16 4:02 PM View: | Buckley Stephen Jr. Director | Eledon Pharmaceuticals, Inc. (NVUS) | 15-Mar-16 | Market Purchase | 8,000 | $5.74 | $45,920.00 | 267% 3.0K to 11.0K | (98%) |
| 08-Jan-16 4:01 PM View: | Morrison Jodie Pope President and CEO Director | Eledon Pharmaceuticals, Inc. (NVUS) | 08-Jan-16 | Option Exercise | 28,015 | $1.16 | $32,449.40 | 95% 29.55K to 57.57K | |
| 12-Nov-15 9:06 AM View: | Buckley Stephen Jr. Director | Eledon Pharmaceuticals, Inc. (NVUS) | 11-Nov-15 | Market Purchase | 3,000 | $11.25 | $33,750.00 | 100% 0 to 3.0K | (99%) |
| 22-Sep-15 4:31 PM View: | McBride John S. Chief Operating Officer | Eledon Pharmaceuticals, Inc. (NVUS) | 21-Sep-15 | Option Exercise | 13,500 | $4.19 | $56,565.00 | 100% 0 to 13.5K | |
| 22-Sep-15 4:31 PM View: | McBride John S. Chief Operating Officer | Eledon Pharmaceuticals, Inc. (NVUS) | 21-Sep-15 | Market Option Sale (Planned) | 13,500 | $14.01 | $189,135.00 | (100%) 13.5K to 0 | 99% |
| 08-Sep-15 4:23 PM View: | Kalowski Lee Chief Financial Officer | Eledon Pharmaceuticals, Inc. (NVUS) | 08-Sep-15 | Market Sale (Planned) | 4,668 | $13.13 | $61,290.80 | (10%) 45.62K to 40.95K | 99% |
| 04-Sep-15 4:03 PM View: | Kalowski Lee Chief Financial Officer | Eledon Pharmaceuticals, Inc. (NVUS) | 02-Sep-15 | Market Sale (Planned) | 2,158 | $12.96 | $27,967.70 | (5%) 47.78K to 45.62K | 99% |
| 30-Jul-15 5:33 PM View: | Morrison Jodie Pope President and CEO Director | Eledon Pharmaceuticals, Inc. (NVUS) | 29-Jul-15 | Market Option Sale (Planned) | 564 | $13.70 | $7,726.80 | (2%) 30.11K to 29.55K | 99% |
| 30-Jul-15 5:33 PM View: | Morrison Jodie Pope President and CEO Director | Eledon Pharmaceuticals, Inc. (NVUS) | 29-Jul-15 | Option Exercise | 10,564 | $0.89 | $9,411.12 | 54% 19.55K to 30.11K | |
| 30-Jul-15 5:33 PM View: | Morrison Jodie Pope President and CEO Director | Eledon Pharmaceuticals, Inc. (NVUS) | 28-Jul-15 | Market Option Sale (Planned) | 12,000 | $13.70 | $164,400.00 | (38%) 31.55K to 19.55K | 99% |
| 30-Jul-15 5:33 PM View: | Morrison Jodie Pope President and CEO Director | Eledon Pharmaceuticals, Inc. (NVUS) | 28-Jul-15 | Option Exercise | 12,000 | $1.58 | $18,960.00 | 61% 19.55K to 31.55K | |
| 24-Jul-15 4:23 PM View: | Morrison Jodie Pope President and CEO Director | Eledon Pharmaceuticals, Inc. (NVUS) | 22-Jul-15 | Option Exercise | 10,000 | $1.06 | $10,624.30 | 105% 9.55K to 19.55K | |
| 17-Jul-15 4:05 PM View: | Novartis Bioventures Ltd 10% Owner | Eledon Pharmaceuticals, Inc. (NVUS) | 15-Jul-15 | Market Sale | 3,566 | $14.26 | $50,844.00 | (< 1%) 4.5M to 4.49M | 99% |
| 15-Jul-15 4:18 PM View: | Novartis Bioventures Ltd 10% Owner | Eledon Pharmaceuticals, Inc. (NVUS) | 14-Jul-15 | Market Sale | 27,861 | $14.41 | $401,477.00 | (< 1%) 4.52M to 4.5M | 99% |
| 15-Jul-15 4:18 PM View: | Novartis Bioventures Ltd 10% Owner | Eledon Pharmaceuticals, Inc. (NVUS) | 13-Jul-15 | Market Sale | 20,611 | $14.20 | $292,717.00 | (< 1%) 4.55M to 4.52M | 99% |
| 30-Jun-15 4:48 PM View: | Morrison Jodie Pope President and CEO Director | Eledon Pharmaceuticals, Inc. (NVUS) | 29-Jun-15 | Option Exercise | 8,000 | $1.58 | $12,640.00 | 84% 9.55K to 17.55K | |
| 30-Jun-15 4:48 PM View: | Morrison Jodie Pope President and CEO Director | Eledon Pharmaceuticals, Inc. (NVUS) | 29-Jun-15 | Market Option Sale (Planned) | 8,000 | $13.70 | $109,600.00 | (46%) 17.55K to 9.55K | 99% |
| 30-Jun-15 4:48 PM View: | Morrison Jodie Pope President and CEO Director | Eledon Pharmaceuticals, Inc. (NVUS) | 26-Jun-15 | Option Exercise | 8,000 | $1.58 | $12,640.00 | 84% 9.55K to 17.55K | |
| 30-Jun-15 4:48 PM View: | Morrison Jodie Pope President and CEO Director | Eledon Pharmaceuticals, Inc. (NVUS) | 26-Jun-15 | Market Option Sale (Planned) | 8,000 | $13.83 | $110,640.00 | (46%) 17.55K to 9.55K | 99% |
